Lloyd Minor, the dean of the Stanford University School of Medicine, stated his affinity for precision health in a blog post last week, citing three trends that he believes irrefutably support his conviction that this holistic approach to medicine is the way of the future.
- The rise of big data. Minor believes that efforts like the New York Genome Center’s work with IBM in the area of big data represent a significant development for precision health and its goal of extracting actionable insights from large volumes of information.
- An increase in the number of predictive devices and preventive tests. The dean expects that new and upcoming gadgets and exams will help caregivers figure out exactly what patients need, and he cites Novartis’ glucose-monitoring contact lens as an example.
- A newfound respect for collaboration. Enthusiastic about the end of silos and the dawn of sharing, Minor lauds an example of collaboration not only being embraced but leveraged as a condition for participation in tech entrepreneur Sean Parker’s $250 million Parker Institute for Cancer Immunotherapy.
Read the full blog-post here.
Dave Bennett, executive vice president, product & strategy, gave an exciting presentation on the shift to precision medicine at Connecting Michigan for Health 2016. Watch it now!